Apr 30, 2026 06:01AM Greenwich LifeSciences delays annual filing amid audit completion

Apr 20, 2026 06:01AM Greenwich LifeSciences presents immunotherapy trial data at cancer meeting

Apr 14, 2026 06:01AM Greenwich LifeSciences reports Q1 cash balance of $10.5 million

Apr 7, 2026 06:00AM Greenwich LifeSciences files patent claims to expand GLSI-100 eligibility

Mar 19, 2026 06:00AM Greenwich LifeSciences adds City of Hope to breast cancer trial

Mar 18, 2026 06:01AM Greenwich LifeSciences to present FLAMINGO-01 trial data at AACR meeting

Mar 17, 2026 06:02AM Greenwich LifeSciences reports reduced breast cancer recurrence rates

Mar 16, 2026 06:00AM Greenwich LifeSciences begins using commercial GP2 in breast cancer trial

Mar 3, 2026 06:01AM Greenwich LifeSciences reports 33% increase in FLAMINGO-01 screening rate

Feb 24, 2026 06:01AM Greenwich LifeSciences Announces Acceptance of Two Abstracts at AACR Annual Meeting 2026

Feb 5, 2026 06:50AM H.C. Wainwright Reiterates Buy Rating on Greenwich LifeSciences (GLSI)

Jan 27, 2026 06:00AM Greenwich LifeSciences raises cash balance to $12.5 million through ATM

Dec 29, 2025 06:01AM Greenwich LifeSciences extends director lock-up to September 2026

Dec 22, 2025 06:00AM Greenwich LifeSciences reports progress on FLAMINGO-01 breast cancer trial

Dec 15, 2025 06:01AM Greenwich LifeSciences reports 80% recurrence reduction in cancer trial

Dec 8, 2025 06:02AM Greenwich LifeSciences completes enrollment in open label arm of phase III trial

Dec 3, 2025 06:00AM Greenwich LifeSciences screens over 1,000 patients in phase III trial

Oct 9, 2025 06:00AM Greenwich LifeSciences adds Austria to Phase III breast cancer trial

Oct 2, 2025 06:00AM Greenwich LifeSciences expands breast cancer trial to Belgium

Sep 30, 2025 06:01AM Greenwich LifeSciences expands FLAMINGO-01 trial to Portugal

Sep 18, 2025 06:01AM Greenwich LifeSciences expands breast cancer trial to Ireland

Aug 20, 2025 09:28AM Noble Capital Starts Greenwich LifeSciences (GLSI) at Outperform

Aug 19, 2025 06:01AM Greenwich LifeSciences builds internal clinical operations team

Aug 13, 2025 06:00AM Greenwich LifeSciences expands breast cancer trial to Romania

Jun 27, 2025 09:00AM Greenwich LifeSciences Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Apr 21, 2025 06:44AM Greenwich LifeSciences (GLSI) PT Raised to $39 at H.C. Wainwright

Apr 3, 2025 08:02AM Greenwich LifeSciences (GLSI) Provides Global Update on FLAMINGO-01

Apr 2, 2025 06:26AM Greenwich LifeSciences (GLSI) Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial

Mar 17, 2025 06:45AM Greenwich LifeSciences (GLSI) Provides Update on Open Label Safety Data from FLAMINGO-01

Feb 10, 2025 06:00AM Greenwich LifeSciences (GLSI) Provides Update on Open Label HLA Data from FLAMINGO-01

Jan 22, 2025 06:03AM Greenwich LifeSciences (GLSI) Provides Update on Commercial Manufacturing

Jan 14, 2025 06:15AM Greenwich LifeSciences (GLSI) Announces Partnership with GBG in Germany for Flamingo-01

Aug 1, 2024 06:25AM Greenwich LifeSciences (GLSI) Provides Update on Expansion of Flamingo-01 into Spain

Jun 26, 2024 07:33AM Greenwich LifeSciences (GLSI) to Rejoin Russell 2000 Index

Jun 14, 2024 06:01AM Greenwich LifeSciences (GLSI) Announces 175K Private Placement at $14.30/sh